SEATTLE — Millions of Amazon Prime members are now seeing refunds after the company agreed to a $2.5 billion settlement with the Federal Trade Commission over how it signed people up for Prime and how ...

If you paid for Amazon Prime but barely used it (or struggled to cancel), you could be owed money. Amazon started issuing refunds as part of a $2.5 billion settlement with the Federal Trade Commission ...

To kick off 2026, Amazon Prime members will be able to download 10 more free games starting this month. Over a dozen separate games will be able to stream via Luna cloud delivery as well. Civilization ...

Have you checked your mail box lately? You might have received an envelope from Amazon. But don’t assume you’re getting scammed — you could be getting a check. On Sept. 25 of last year, Amazon settled ...

Amazon is launching a major upgrade to its streaming service — one that expands the type of content available and comes at no additional cost. Prime Video is rolling out a dedicated news destination ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

SEATTLE — Amazon is giving U.S. Prime Video subscribers a big new benefit at no extra cost. The streaming service has added a special news section that shows live news channels right inside the app.

For those of you who are usually glued to the news networks, and also have Amazon Prime Video, something great comes this way. While quite a few of the major streaming platforms such as Netflix, Apple ...

Dalton Cooper is the Managing Editor of GameRant. Dalton has been writing about video games professionally since 2011. Having written thousands of game reviews and articles over the course of his ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...